Finian McGrath (Dublin North Central, Independent)
Link to this: Individually | In context | Oireachtas source

To ask the Minister for Health if he will support the new drug for Cystic Fibrosis patients (details supplied) [47802/12]

Alex White (Dublin South, Labour)
Link to this: Individually | In context | Oireachtas source

The HSE recently received an application for Kalydeco's inclusion under the Community Drugs Scheme. In accordance with normal procedures, the National Centre for Pharmacoeconomics must conduct a Health Technology Assessment (HTA) on this product which will consider if the drug is cost effective at the price offered to the HSE. No reimbursement decision will be made until the HTA has been completed.